TY  - JOUR 
AU  - Ortea García, Ignacio
AU  - Roschitzki, B
AU  - Ovalles, J G
AU  - Longo, J L
AU  - de la Torre, I
AU  - Gonzalez, I
AU  - Gómez-Reino Carnota, Juan Jesús
AU  - González Martínez-Pedrayo, Antonio
AU  - González, I
PY  - 2012
SN  - 1874-3919
UR  - http://hdl.handle.net/20.500.11940/4781
AB  - Biologics such as TNF antagonists are a new class of drugs that have greatly improved Rheumatoid Arthritis (RA) treatment. However, for unknown reasons, individual patients with RA respond to one of these drugs but not to others even those targeting...
LA  - eng
TI  - Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: An exploratory analysis
DO  - 10.1016/j.jprot.2012.09.011
T2  - Journal of Proteomics
M2  - 372
VL  - 77
ER  -